We are closely monitoring the development of COVID-19, specifically in relation to our day to day working activities and any impact that this may have on our work, collaborations and staff. We are following UK Government advice and continue to operate as business as usual. Plans are in place to minimise impact to our Development Centre activities, and special provisions are being put in place for our Manufacturing Centre to ensure therapies can continue to be produced.

If you have any further questions, please feel free to contact our COVID-19 team directly COVID-19@ct.catapult.org.uk

Cell and Gene Therapy Catapult
Whether you're at the very start of your research, looking to manufacture therapies, or need regulatory support, we can help.
How we work with you

We have the infrastructure and a team of specialists across the cell and gene therapy life cycle, who will work with you when you need us, to enable you to get the best possible results. We have a range of approaches that can help tackle the challenges you might face in the development of cell and gene therapies. We’ll work with you to accelerate your projects, helping your cell and gene therapies to be safer, more effective, scalable and affordable. We make it our job to stay at the forefront of the latest innovations in cell and gene therapies, so that we're ready to help, whenever you might need us.

Watch this video

About Cell and Gene Therapy Catapult - Interview with CEO Keith Thompson

Who we work with

Latest event

27 May
Wed 09:00

This bespoke course, designed in collaboration with the industry's leading Advanced Therapy Medicinal Products (ATMP) manufacturers, aims to provide comprehensive training for practitioners working in Advanced Therapy Medicinal Products manufacturing.

  • Today we say a heartfelt THANK YOU 👏 to Keith Thompson for his tireless work and eight successful years as founding… https://t.co/2701GZP40J 19 hours 26 min ago

Discover who we are